• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (SMALL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (SMALL) Back to Search Results
Catalog Number AB-20260
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cellulitis (1768); Unspecified Infection (1930); Seroma (2069); Fluid Discharge (2686)
Event Date 04/23/2014
Event Type  Injury  
Event Description
Healthcare professional reported, "port site infection - gp started oral ab.F/u [surgeon] - cellulitis over port, discharging seroma.Admitted to [hospital] [five days] for iv antibiotics".Final diagnosis - "wound infection - ongoing review".
 
Manufacturer Narrative
The product associated with this report has not been returned as the device was not explanted.Based upon the model number, serial number and implant date provided by the reporter the connector type is assumed to be a taper ii.The reporter of the event was asked to return the product for analysis, if it is explanted in the future.The pt has been treated with antibiotics and the device remains implanted, so allergan has not received the device nor performed analysis at this time.Cellulitis, infection, seroma and drainage are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.No additional info has been reported to allergan regarding the diagnostic testing, pt data or further event details.Device labeling addresses the possible outcome of an infection as follows: "infection can occur in the immediate post-operative period or years after insertion of the device.In the presence of infection or contamination, removal of the device is indicated".Device labeling addresses the reported event of seroma, cellulitis and drainage as follows: "it is important to discuss all possible complications and adverse events with your pt.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the pt's degree of intolerance to any foreign object implanted in the body".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP ADJUSTABLE GASTRIC BANDING SYSTEM (SMALL)
Manufacturer (Section D)
ALLERGAN
la aurora de heredia
CS 
Manufacturer (Section G)
COSTA RICA
900 parkway global park zone franca
la aurora de heredia
CS  
Manufacturer Contact
karen herrera
71 south los carneros road
goleta, CA 93117
8059615867
MDR Report Key3839259
MDR Text Key15820087
Report Number2024601-2014-00266
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/02/2015
Device Catalogue NumberAB-20260
Device Lot Number2533194
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/29/2014
Initial Date FDA Received05/20/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age56 YR
-
-